US-EU Index Rebalances / Quantitative Researcher

Dimitris Ioannidis

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

Index Rebalance

<ul>
<li>The acquisition of <a href="https://www.smartkarma.com/entities/ansys-inc" target="_blank" data-smartkarma-citation="entities:15473:1" rel="noopener">Ansys Inc (ANSS US)</a> by <a href="https://www.smartkarma.com/entities/synopsys-inc" target="_blank" data-smartkarma-citation="entities:3493:1" rel="noopener">Synopsys Inc (SNPS US)</a> has been completed today, 17 July and Ansys is expected to be deleted from Nasdaq100.</li>
<li>
<a href="https://www.smartkarma.com/entities/coreweave-inc" target="_blank" data-smartkarma-citation="entities:44471:1" rel="noopener">CoreWeave (CRWV US)</a> is forecasted to be added to Nasdaq100 as the replacement because it is the highest ranked eligible non-constituent following its recent listing on 28 March 2025.</li>
<li>Top addition candidate for the December 2025 annual review is now <a href="https://www.smartkarma.com/entities/kimberly-clark-corp" target="_blank" data-smartkarma-citation="entities:2292:1" rel="noopener">Kimberly Clark (KMB US)</a> following its listing transfer from NYSE to Nasdaq on 30 May 2025.</li>
</ul>


The acquisition of Ansys Inc (ANSS US) by Synopsys Inc (SNPS US) has been completed today, 17 July and Ansys is expected to be deleted from Nasdaq100.

CoreWeave (CRWV US) is forecasted to be added to Nasdaq100 as the replacement because it is the highest ranked eligible non-constituent following its recent listing on 28 March 2025.
Top addition candidate for the December 2025 annual review is now Kimberly Clark (KMB US) following its listing transfer from NYSE to Nasdaq on 30 May 2025.


CoreWeave (CRWV US): Forecasted Addition to Nasdaq100 Replacing Ansys Post-Acquisition

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Kimberly-Clark's recent earnings provided a detailed overview of its performance in the first quarter of 2025 and its strategic outlook moving forward.</li><li>The company's results showed a softer top line than expected, though they were aligned with the full-year plan expectations.</li><li>Kimberly-Clark remains focused on its Powering Care strategy, emphasizing innovation across a spectrum of consumer offerings.</li></ul>

Kimberly-Clark's recent earnings provided a detailed overview of its performance in the first quarter of 2025 and its strategic outlook moving forward.The company's results showed a softer top line than expected, though they were aligned with the full-year plan expectations.Kimberly-Clark remains focused on its Powering Care strategy, emphasizing innovation across a spectrum of consumer offerings.

Kimberly-Clark: Consumer-Centric Product Strategy to Reinforce Brand Trust & Enhance The Customer Base!

Global Healthcare Analyst

Tina Banerjee

<ul>
<li>
<a href="https://www.smartkarma.com/entities/ansell-ltd" target="_blank" data-smartkarma-citation="entities:10777:1" rel="noopener">Ansell Ltd (ANN AU)</a> reported 30% YoY growth in revenue to $1,019M in 1HFY25 backed by strong Healthcare and Industrial business contribution. EBIT margin expanded 250bps to 12.5%.</li>
<li>KBU integration is progressing well and APIP measures bearing fruit generating higher savings. The company has realized a savings of $22M in H1FY25, compared to $7M in H1FY24.</li>
<li>Ansell revised FY25 adjusted EPS from $1.10–1.27 to $1.18–1.28, with the midpoint beating consensus. Management expects continued organic constant currency sales growth in H2FY25, but slower than H1FY25.</li>
</ul>



Ansell Ltd (ANN AU) reported 30% YoY growth in revenue to $1,019M in 1HFY25 backed by strong Healthcare and Industrial business contribution. EBIT margin expanded 250bps to 12.5%.
KBU integration is progressing well and APIP measures bearing fruit generating higher savings. The company has realized a savings of $22M in H1FY25, compared to $7M in H1FY24.
Ansell revised FY25 adjusted EPS from $1.10–1.27 to $1.18–1.28, with the midpoint beating consensus. Management expects continued organic constant currency sales growth in H2FY25, but slower than H1FY25.


Ansell Ltd (ANN AU): Healthcare Business Revival Drives H1 Result; FY25 Guidance Raised

<ul><li>Kimberly-Clark reported its fourth quarter and full-year 2024 results, highlighting several key elements that provide insight into the company's current positioning and future prospects.</li><li>The company unveiled its Powering Care transformation strategy, which restructures its organization into three main segments, aiming for optimized growth and efficiency.</li><li>This structure hopes to foster an environment conducive to volume and mix-driven growth, targeting expansion ahead of its market categories.</li></ul>

Kimberly-Clark reported its fourth quarter and full-year 2024 results, highlighting several key elements that provide insight into the company's current positioning and future prospects.The company unveiled its Powering Care transformation strategy, which restructures its organization into three main segments, aiming for optimized growth and efficiency.This structure hopes to foster an environment conducive to volume and mix-driven growth, targeting expansion ahead of its market categories.

Kimberly-Clark: Market Focus & Expansion Strategies As A Primary Growth Accelerator! - Major Drivers

<ul><li>Kimberly-Clark has delivered a mixed performance in its third quarter of 2024, characterized by strategic progress amidst notable challenges.</li><li>In the earnings discussion, CEO Mike Hsu emphasized successful advances in the company's Powering Care strategy, which aims to position Kimberly-Clark as a global leader in their categories.</li><li>This strategy includes fostering innovation, optimizing productivity to support growth initiatives, and restructuring the organization to enhance efficiency and competitiveness.</li></ul>

Kimberly-Clark has delivered a mixed performance in its third quarter of 2024, characterized by strategic progress amidst notable challenges.In the earnings discussion, CEO Mike Hsu emphasized successful advances in the company's Powering Care strategy, which aims to position Kimberly-Clark as a global leader in their categories.This strategy includes fostering innovation, optimizing productivity to support growth initiatives, and restructuring the organization to enhance efficiency and competitiveness.

Kimberly-Clark Corporation:  Strategic Growth Plan Leveraging Major Brands & New Market Initiatives! - Major Drivers

United States

Kimberly-Clark Corporation is a global health and hygiene company that manufactures and provides consumer products. The Company's products include diapers, tissues, paper towels, incontinence care products, surgical gowns, and disposable face masks.  Kimberly-Clark's products are sold in countries around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kimberly Clark (KMB US)

CoreWeave (CRWV US): Forecasted Addition to Nasdaq100 Replacing Ansys Post-Acquisition

Thomson Reuters (TRI) will replace ANSS instead. Reuters was considered to be in the category of financial data providers - alongside FactSet and...

Dimitris Ioannidis

Kimberly-Clark: Consumer-Centric Product Strategy to Reinforce Brand Trust & Enhance The Customer Base!

Kimberly-Clark's recent earnings provided a detailed overview of its performance in the first quarter of 2025 and its strategic outlook moving...

Baptista Research

Ansell Ltd (ANN AU): Healthcare Business Revival Drives H1 Result; FY25 Guidance Raised

Ansell sees 30% YoY revenue growth in 1HFY25, with EBIT margin expanding 250bps to 12.5%. The company has revised FY25 adjusted EPS from...

Tina Banerjee

Kimberly-Clark: Market Focus & Expansion Strategies As A Primary Growth Accelerator! - Major Drivers

Kimberly-Clark reported its fourth quarter and full-year 2024 results, highlighting several key elements that provide insight into the company's...

Baptista Research

Kimberly-Clark Corporation: Strategic Growth Plan Leveraging Major Brands & New Market Initiatives! - Major Drivers

Kimberly-Clark has delivered a mixed performance in its third quarter of 2024, characterized by strategic progress amidst notable challenges. In...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

CoreWeave (CRWV US): Forecasted Addition to Nasdaq100 Replacing Ansys Post-Acquisition

Thomson Reuters (TRI) will replace ANSS instead. Reuters was considered to be in the category of financial data providers - alongside FactSet and...

Dimitris Ioannidis

Kimberly-Clark: Consumer-Centric Product Strategy to Reinforce Brand Trust & Enhance The Customer Base!

Kimberly-Clark's recent earnings provided a detailed overview of its performance in the first quarter of 2025 and its strategic outlook moving...

Baptista Research

Ansell Ltd (ANN AU): Healthcare Business Revival Drives H1 Result; FY25 Guidance Raised

​Ansell sees 30% YoY revenue growth in 1HFY25, with EBIT margin expanding 250bps to 12.5%. The company has revised FY25 adjusted EPS from...

Tina Banerjee

Kimberly-Clark: Market Focus & Expansion Strategies As A Primary Growth Accelerator! - Major Drivers

Kimberly-Clark reported its fourth quarter and full-year 2024 results, highlighting several key elements that provide insight into the company's...

Baptista Research

Kimberly-Clark Corporation: Strategic Growth Plan Leveraging Major Brands & New Market Initiatives! - Major Drivers

Kimberly-Clark has delivered a mixed performance in its third quarter of 2024, characterized by strategic progress amidst notable challenges. In...

Baptista Research

Ansell sees 30% YoY revenue growth in 1HFY25, with EBIT margin expanding 250bps to 12.5%. The company has revised FY25 adjusted EPS from...